Alphabet-backed start-up Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine. Johnson & Johnson's Janssen Biotech unit is the ...
Nearly two years after Google DeepMind released an updated AlphaFold3 geared at drug discovery, its biopharmaceuticals spin-off, Isomorphic Labs, announced an even more powerful ...
The unveiling of the Isomorphic Labs Drug Design Engine (IsoDDE) represents a fundamental shift from merely predicting the shape of biological life to actively engineering its functions. While ...
Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.
Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.
Abstract: The identification and enumeration of small, non-isomorphic graphs, called graphlets, within larger graphs is an analytic tool used for graph analytics. The problem of identifying graphlets ...
Memgraph Creates Toolkit for Non-Graph Users to Jumpstart the Journey to Full GraphRAG AI Capability
Memgraph, a leader in open-source in-memory graph databases purpose-built for dynamic, real-time enterprise applications, is releasing two new tools specifically architected to open up the power of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results